STAT+: FDA approves Roivant therapy for rare autoimmune disease
STAT News · LC · trust 47/100
The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease.
Read the original at STAT News →
Open in TruthVane →